1. Home
  2. CCEL vs UG Comparison

CCEL vs UG Comparison

Compare CCEL & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • UG
  • Stock Information
  • Founded
  • CCEL 1989
  • UG 1942
  • Country
  • CCEL United States
  • UG United States
  • Employees
  • CCEL N/A
  • UG N/A
  • Industry
  • CCEL Managed Health Care
  • UG Package Goods/Cosmetics
  • Sector
  • CCEL Health Care
  • UG Consumer Discretionary
  • Exchange
  • CCEL Nasdaq
  • UG Nasdaq
  • Market Cap
  • CCEL 39.9M
  • UG 36.9M
  • IPO Year
  • CCEL 1997
  • UG N/A
  • Fundamental
  • Price
  • CCEL $4.91
  • UG $8.10
  • Analyst Decision
  • CCEL Strong Buy
  • UG
  • Analyst Count
  • CCEL 1
  • UG 0
  • Target Price
  • CCEL $8.50
  • UG N/A
  • AVG Volume (30 Days)
  • CCEL 13.1K
  • UG 3.3K
  • Earning Date
  • CCEL 07-22-2025
  • UG 08-08-2025
  • Dividend Yield
  • CCEL 20.49%
  • UG 8.64%
  • EPS Growth
  • CCEL N/A
  • UG 4.93
  • EPS
  • CCEL 0.01
  • UG 0.63
  • Revenue
  • CCEL $32,102,750.00
  • UG $11,408,154.00
  • Revenue This Year
  • CCEL $2.49
  • UG N/A
  • Revenue Next Year
  • CCEL $0.95
  • UG N/A
  • P/E Ratio
  • CCEL $540.48
  • UG $13.14
  • Revenue Growth
  • CCEL 2.33
  • UG N/A
  • 52 Week Low
  • CCEL $4.75
  • UG $7.73
  • 52 Week High
  • CCEL $9.43
  • UG $16.25
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 43.10
  • UG 46.14
  • Support Level
  • CCEL $5.00
  • UG $8.00
  • Resistance Level
  • CCEL $6.35
  • UG $8.29
  • Average True Range (ATR)
  • CCEL 0.27
  • UG 0.14
  • MACD
  • CCEL -0.02
  • UG -0.00
  • Stochastic Oscillator
  • CCEL 3.77
  • UG 36.59

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: